We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MEDICARE ACT MAKES REIMBURSEMENT BIGGER ISSUE, AZAR SAYS
MEDICARE ACT MAKES REIMBURSEMENT BIGGER ISSUE, AZAR SAYS
April 15, 2004
During the next two years, the implementation of the Medicare Prescription Drug, Improvement and Modernization Act will have a greater impact on drugmakers than the drug-review process at the FDA, according to the top lawyer at HHS.